There is no TGA-registered BPC-157 product for therapeutic use in Australia, and as of June 2024 BPC-157 is a Schedule 4 (prescription-only) substance, meaning any legal supply must come through a doctors prescription via a compounding pharmacy
It can also change how your pelvic floor feels and functions
The Melanotan-1 fda approved status for injectable forms doesn't exist because no manufacturer has ever completed the clinical trial pathway necessary to file a New Drug Application
The premium over research peptide pricing reflects the regulatory infrastructure, prescriber consultations, and standardized compounding processes
How does retatrutide differ from semaglutide and tirzepatide
Vitality & Recovery Recovery IV + Glutathione 60 min | 2 medical credits Formulated for patients recovering from illness, surgery, or sustained physical stress